drugset / Trial / NCT00811096

Pilot Human Study of Tinidazole Efficacy For Radical Cure Of Plasmodium Vivax

NCT00811096

Phase 2 Completed 20 enrolled Walter Reed Army Institute of Research (WRAIR)
RandomizedParallel-groupOpen-labelTreatment

Summary

Assess the efficacy of 2 grams of tinidazole given for 5 days with standard dose chloroquine to achieve radical cure of Plasmodium vivax within a 90 day follow-up period sufficient to justify an IND and formal phase II evaluation.

Timeline

Start
2008-11
Primary completion
2009-01
Completion
2009-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Chloroquine Small molecule Oral
Subject tinidazole Small molecule 2 g Oral